Cleveland Clinic Taussig Cancer Institute
Avatar

Novel Therapies Beyond Single Agent JAK Inhibitors: New Therapies and Combinations from ASH 2017

By Cleveland Clinic Taussig Cancer Institute FEATURING Aaron Gerds
By Cleveland Clinic Taussig Cancer Institute FEATURING Aaron Gerds
293 views
March 5, 2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
08:44
American Contact Dermatitis Society (ACDS)

What to Do When Patch Testing is Negative?

Feat. M. Montanez-Wiscovich
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
11:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Myeloproliferative Neoplasms

Feat. E. Hexner
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
22:30
Indy Hematology Review

Targets and Treatments of MPNs in 2023

Feat. R. Mesa
23:12
Total Health

West Oncology Conference: Overview and Updates in MPNs

Feat. J. Chandler
09:08
Paul Kaesberg

Itching in PV (and Other MPNs)

08:24
ASH 2022 Conference Coverage

Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…

Feat. A. Vannucchi
17:49
Yale Cancer Center

Yale ASH Highlights - Myeloid Malignancies: Focus on MPNs

Feat. N. Podoltsev
32:39
MyCancerHaven

Experts Discuss the Basics of Allogeneic Stem Cell Transplant

Feat. R. Vij, M. Christopher
16:48
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibro…

Feat. A. Hunter
20:06
UChicago Medicine

Updates in MPNs

Feat. A. Patel
06:46
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML U…

Feat. S. Urrutia
17:23
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

New Approaches to Preventing and Treating GVHD

Feat. N. Hossain
15:35
SOHO Turkey 2023

SOHO Turkey 2023: WHO Classification of MPNs - Transitioning From th…

Feat. H. Hamed
10:51
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: Myeloproliferative Neoplasms

Feat. J. Mascarenhas